• New allergen-specific therapeutic strategies
• Genetic/environment interactions in preventing allergic diseases
• Basophil activation: Current evaluation methods
• Complementary medicine in allergic disease, a fact of life: How should we respond?
• Sublingual allergen immunotherapy: Effective and safe
• Antihistamine preparations of new generation
• Risk factors in allergic children: A multiethical approach
• The impact of allergic diseases
• Atopic dermatitis
• Allergic conjunctivitis
• Allergens and bronchial obstruction
• New future treatments in allergy
• New perspectives in allergen immunotherapy
• Pollinosis in the world, old and new problems
• Recombinant allergens biological and clinical aspects
• Pre-IgE to IgE era: Four decades of clinical experience in allergic rhinitis
• How to modulate nasal inflammation in allergy
• T γ/δ cells in allergic nasal inflammation
• Nasal allergy and otitis media: Relationship and controversies
• Comorbidity in allergic rhinitis
• The ARIA Guidelines (asthma and rhinitis guidelines)
• Global Alliance against Respiratory Diseases (GARD)
• New insights into the pathophysiology of chronic urticaria
• Chemokines in asthma
• Virus infections and atopic asthma - immunologic mechanisms
• Stress and asthma
• Role of dendritic cells in asthma
• Atopy and asthma genes
• Airways remodelling in asthma
• The role of T lymphocytes in the development of late phase allergic reactions in the lungs of asthma patients
• Cytokines of TNF family and asthma
• Role of environmental factors in allergy and asthma
• Epidemiology of asthma
• Treatment of severe asthma
• Immunotherapy in allergy and asthma
• Anti-IgE therapy
• Allergen peptide immunotherapy
• Anti-IL4 and IL5 therapies
• Asthma induced by pine tree pollen
• Aspirin-induced asthma
• Asthma and sports

• Transcriptional regulation of immune tolerance and reactivity
• Development of effector and regulatory T cells
• Th17 cells functions and effector mechanisms. Interaction with other cells
• T and B cell memory and immune regulation
• Natural killer cells: a first line defense
• Dendritic cell subsets and immune regulation
• Chemokines and receptors in peripheral tolerance
• Immune senescence and peripheral tolerance
• Apoptosis in the regulation of immune response
• Mechanisms of immune privilege
• The role of microRNAs in immune regulation and effector functions
• New advances in flow cytometry and cell sorting
• Thymosin peptides in the diagnostics and treatment of cancer and infectious diseases
• Immunotherapy of cancer
• Tumor antigen-specific T cell tolerance
• Cytokines and immunopathology
• Immunomodulating preparations: classification, main principles of therapeutic use
• Conjugated polymer-subunit immunogenes and vaccines
• Primary immunodeficiency diseases
• Inherited interferon deficiency
• Gastrointestinal mucosal immunopathology
• Role of immune response in sepsis and septic shock
• The immunopharmacology of infectious diseases
• Tolerating the nervous system: a delicate balance
• Neuroimmunomodulation in health and disease
• The neuroendocrine stress response in autoimmune, allergic and infectious disease susceptibility and resistance
• Physiological problems of transplantology
• Stem cells: Value for basic science and applied medicine
• Possible therapeutic use of stem cells
• Gene diagnostics & gene therapy in immunopathology
• Bioterrorism: Immunological aspects
• Pathogenesis of HIV infection
• New hope for an AIDS vaccine
• Cytokines in AIDS diagnostics and treatment

• Toll-like receptors in autoimmunity
• Autoimmune epitopes: autoepitopes
• Apoptosis and SLE: in vivo and in vitro studies
• Neurotransmitters and immunology interactions
• Pathogenesis in autoimmune cardiomyopathy
• Autoimmunity predisposing genes
• Genes involved in tolerance and autoimmunity
• Role of AIRE gene and ectopic thymic expression of parenchymal antigens in development of autoimmune diseases
• Role of dendritic cells in the induction of tolerance/autoimmunity
• Carbon monoxide as an antiinflammatory mediator and HO-1 expression in autoimmunity
• Chemokines and their receptors in autoimmune diseases
• Cell adhesion molecules in arthritis and autoimmune diseases
• Food antigens and autoimmunity
• Environment versus genetics in autoimmunity
• Mast cells and autoimmunity
• Anti-receptor autoantibodies
• Natural autoimmunity
• New technologies in the detection of autoantibodies especially antigen arrays and addressable laser beads
• Challenges for the clinical autoantibody laboratory
• New challenges for autoantibody testing in the brave new world of biological therapeutics
• Autoimmunity and pregnancy
• Atherosclerosis and autoimmunity
• Rheumatoid arthritis, new therapies for autoimmune disorders
• Modern methods in diagnostics of diabetes
• Type 1 diabetes: New technologies in prevention and treatment
• Gene therapy and autoimmune disease
• Peptide therapy and autoimmune disease
• Biologics as therapies of autoimmunity
• Remodelling in systemic autoimmune diseases by differentiated stem cells or gene therapy
• Therapeutical vaccines for autoimmune diseases, T cell vaccination, drug-vaccines against myasthenia gravis, drugs-vaccines against lupus